Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cells to Investigate How ACTL6A and p63 Activate Hippo-YAP in SCC

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE88861 | GEO | 2016/11/18

SECONDARY ACCESSION(S): PRJNA348817

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

ChIP-Seq Samples for p63 in HNSCC Cells to Investigate How ACTL6A and p63 Activate Hippo-YAP in SCC

Project description:Loss-of-function mutations in SWI/SNF chromatin remodeling subunit genes are observed in many cancers, but an oncogenic role for SWI/SNF is not well established. Here we reveal that ACTL6A, encoding a SWI/SNF subunit linked to stem and progenitor cell function, is frequently co-amplified and highly expressed together with the p53 family member p63 in head and neck squamous cell carcinoma (HNSCC). ACTL6A and p63 physically interact and cooperatively control a transcriptional program that promotes proliferation and suppresses differentiation, in part through activation of the Hippo-YAP pathway via regulators including WWC1. Consequently, loss of ACTL6A or p63 in tumor cells induces YAP phosphorylation and inactivation, associated with growth arrest and terminal differentiation, all phenocopied by WWC1 overexpression. In vivo, ectopic ACTLC6A/p63 expression promotes tumorigenesis, while ACTL6A expression and YAP activation are highly correlated in primary HNSCC and predict poor patient survival. Thus, ACTL6A and p63 collaborate as oncogenic drivers in HNSCC.

2016-11-18 | GSE88859 | GEO

Microarray Samples for shTP63 in HNSCC Cells to Investigate How ACTL6A and p63 Activate Hippo-YAP in SCC

2016-11-18 | GSE88833 | GEO

Microarray Samples for shTP63 in Immortalized HFK to Investigate How ACTL6A and p63 Activate Hippo-YAP in SCC

2016-11-18 | GSE88832 | GEO

Microarray Samples for shACTL6A in HNSCC Cells to Investigate How ACTL6A and p63 Activate Hippo-YAP in SCC

2016-11-18 | GSE88831 | GEO

Cells to Investigate How ACTL6A and p63 Activate Hippo-YAP in SCC

Project description:Cells to Investigate How ACTL6A and p63 Activate Hippo-YAP in SCC

| PRJNA348817 | ENA

Pi3kcb links Hippo-YAP and PI3K-AKT signaling pathways to promote cardiomyocyte proliferation and survival

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2015-02-20 | E-GEOD-57719 | biostudies-arrayexpress

ZDHHC15 mediates Hippo/YAP pathway palmitoylation and regulates tumor progression

Project description:This SuperSeries is composed of the SubSeries listed below.

2024-12-17 | GSE235259 | GEO

SCC of the vulva

Project description:This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

2013-01-16 | E-GEOD-38230 | biostudies-arrayexpress

ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis.

Project description:Loss-of-function mutations in SWI/SNF chromatin-remodeling subunit genes are observed in many cancers, but an oncogenic role for SWI/SNF is not well established. Here, we reveal that ACTL6A, encoding an SWI/SNF subunit linked to stem cell and progenitor cell function, is frequently co-amplified and highly expressed together with the p53 family member p63 in head and neck squamous cell carcinoma (HNSCC). ACTL6A and p63 physically interact, cooperatively controlling a transcriptional program that promotes proliferation and suppresses differentiation, in part through activation of the Hippo-YAP pathway via regulators including WWC1. Ectopic ACTL6A/p63 expression promotes tumorigenesis, while ACTL6A expression and YAP activation are highly correlated in primary HNSCC and predict poor patient survival. Thus, ACTL6A and p63 collaborate as oncogenic drivers in HNSCC.

| S-EPMC5225026 | biostudies-literature

Convergence of YAP/TAZ, TEAD and P63 activity directs premalignant lung gene expression

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-05-09 | GSE213656 | GEO